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S U M M A R Y
Objectives: Qnr-mediated quinolone resistance is increasingly detected worldwide, but few studies have
been carried out so far in Brazil. The aim of this study was to test for qnr determinants in isolates of
ciproﬂoxacin-resistant Klebsiella pneumoniae.
Methods: Fifteen ciproﬂoxacin-resistant isolates from urine cultures of hospitalized patients at a
university hospital in North-East Brazil were investigated. Speciﬁc PCRs were performed for blaCTX-M and
blaTEM, qnr, and class 1 integrons. Plasmid analyses and sequence type (ST) determination were
performed, as described previously.
Results: The KP 930 isolate showed qnrA1 and blaTEM-1, together with dfrA12 and aadA2 in a class 1
integron. The qnr gene was located in a 133-kb plasmid. Multilocus sequence typing classiﬁed the isolate
as ST147.
Conclusions: We identiﬁed the combination of qnr with ST147 in Brazil; this is a clone that has
disseminated widely and successfully in Latin America. The purpose of describing Qnr-mediated
quinolone resistance in North-East Brazil is to draw attention to the spread of this mechanism in the
country.
 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/3.0/).
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jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Introduction
The ﬁrst case of plasmid-mediated resistance to quinolones was
described in the USA in a strain of Klebsiella pneumoniae.1 The gene
that was discovered, called qnr, encodes a pentapeptide, Qnr,
which is responsible for protecting the enzyme DNA gyrase against
inhibition by ﬂuoroquinolones.2 Since it was ﬁrst characterized,
the qnr gene has been reported in Escherichia coli, K. pneumoniae,
and other members of the Enterobacteriaceae family in several
countries, including Brazil.3,4 Its rapid spread is of concern because
it might affect the future clinical use of ﬂuoroquinolones. This
study describes the isolation and characterization of a strain of
K. pneumoniae containing qnrA1 in North-East Brazil.* Corresponding author. Tel.: +55 81 3320 6300.
E-mail address: annacalmeida@hotmail.com (A.C.S. Almeida).
http://dx.doi.org/10.1016/j.ijid.2014.04.026
1201-9712/ 2014 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).2. Materials and methods
In April 2010, a strain of Qnr-producing K. pneumoniae (KP 930)
was obtained from a 41-year-old female patient who was HIV- and
human T cell lymphotropic virus (HTLV)-positive. Species identiﬁ-
cation was performed by means of conventional biochemical tests,
namely positive results for MacConkey growth, citrate (Simmons),
urea hydrolysis, D-glucose acid/gas, sucrose fermentation, lactose
fermentation, and esculin hydrolysis, and negative results for
indole production, hydrogen sulﬁde production, ornithine decar-
boxylase, and motility (36 8C). Susceptibility tests were conducted
by broth microdilution method.5
Speciﬁc PCRs were performed for blaCTX-M and blaTEM, qnr, and
class 1 integron (intI1) and its variable region. The PCR products
were sequenced with a 3500 Genetic Analyzer. The nucleotide
sequences were evaluated through the BioEdit program and were
submitted to online BLASTn analysis at GenBank (National Centerciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
Table 1
Characterization of qnrA1-positive Klebsiella pneumoniae isolate (KP 930), its transformant cell (T 930), and the Escherichia coli DH5a recipient strain
Strain MICs (mg/ml) for antibiotica Plasmid size (kb)
GEN CRO CTX CAZ MEM AMC TZP CIP TGC PMB
KP 930 8 0.12 <0.12 0.25 <0.015 16 16 >8 4 <0.12 133; 118; 2.5
T 930 0.5 0.12 <0.12 0.25 <0.015 2 <2 0.25 0.06 <0.12 133
E. coli DH5a 0.5 0.06 <0.12 0.25 <0.015 <1 <2 <0.004 0.06 <0.12 -
MIC, minimum inhibitory concentration.
a AMC, amoxicillin/clavulanic acid; CAZ, ceftazidime; CIP, ciproﬂoxacin; CRO, ceftriaxone; CTX, cefotaxime; GEN, gentamicin; MEM, meropenem; PMB, polymyxin B; TGC,
tigecycline; TZP, piperacillin/tazobactam.
L.K.L. Rocha et al. / International Journal of Infectious Diseases 26 (2014) 49–5050for Biotechnology Information, NCBI). Plasmid extraction was
performed by alkaline lysis miniprep protocol and the E. coli R861
and E. coli TOP 10 strains were used as controls. Transformation
was performed with E. coli DH5a as the recipient strain.
The transformants were selected on LB (Luria-Bertani) agar
plates containing 0.03 mg/ml of ciproﬂoxacin. The Inc group of the
plasmid harboring the qnr gene was determined in accordance
with Carattoli et al.6 Multilocus sequence typing (MLST) was
performed in accordance with Diancourt et al.7
This work was approved by the Ethics Committee of the State
University of Pernambuco, Brazil (reference number 111/10).
3. Results
The minimum inhibitory concentrations (MICs) for the clinical
isolate of KP 930, transformant (T 930), and the recipient cells are
shown in Table 1. We observed a 62-fold increase in ciproﬂoxacin
MIC values of the transformant cells when compared with the
recipient strain. The qnrA1 gene was identiﬁed in both the donor
and transformed cells. In the search for beta-lactamase genes, only
blaTEM-1 was detected.
The positive PCR for intI1 indicated the isolate to be carrying
class 1 integron, and sequencing of the variable region revealed the
genes dfrA12 and aadA2, which confer resistance to trimethoprim
and aminoglycosides, respectively.
The analysis of the plasmids showed that KP 930 contained the
133, 118, and 2.5 kb plasmids; the ﬁrst of these was also present in
the transformed cells, which indicated where the qnr gene was
located. MLST analysis of the isolate of KP 930 revealed ST147.
4. Discussion
This work represents the ﬁrst study of plasmid-mediated Qnr
resistance to ﬂuoroquinolones in North-East Brazil, although the
qnrA1 allele that was found has already been described in this
country.3 In addition, as far as we are aware, this is the ﬁrst time
that K. pneumoniae ST147 harboring the qnr gene has been
detected in Latin America.
The presence of the qnr gene usually causes only a reduced
sensitivity to ciproﬂoxacin.2 In this study, the resulting elevated
MIC value of the transformed cells did not reach the range of
resistance values, which is consistent with what occurs when the
qnr gene is present alone. The high resistance levels observed in
KP 930 were probably due to a combination of other mechanisms,
mainly chromosomal mutations in the quinolone resistance
determinant region (QRDR).4 Moreover, additional non-plasmid-
mediated mechanisms could explain the higher MIC values in
KP 930 for the other antimicrobials tested, despite the fact that
they did not reach the resistance range.The transformation experiments showed the presence of the
qnr gene in a 133-kb plasmid belonging to the IncX group, which
has often been associated with qnr genes, in particular qnrS1.8
However, no association with qnrA1 has been reported so far.
The K. pneumoniae ST147 identiﬁed in this study corresponds to
an epidemic clone that is described as a blaCTX-M-15 producer and
responsible for its dissemination.9 More recently, ST147 has also
been related to the dissemination of qnr in Europe.10 Here we
describe the association of qnr with ST147 in Brazil.
The results that are provided here raise the possibility that qnr
genes might become widespread in Brazil and that they show the
presence of K. pneumoniae ST147, a clone that has disseminated
widely and successfully in Latin America.
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